Literature DB >> 1581591

Portable stimulus generator for obtaining high-frequency (8-14 kHz) auditory brainstem responses.

S A Fausti1, R H Frey, J A Henry, P G Robertson, R S Hertert.   

Abstract

Currently, the most useful application of high-frequency (greater than or equal to 8 kHz) auditory evaluation is for serial monitoring of patients receiving potentially ototoxic agents. Many individuals, however, are unable to respond to behavioral auditory test techniques. An objective evaluation method such as the auditory brainstem response (ABR) is valuable with difficult-to-test individuals. Laboratory instrumentation has been demonstrated to evoke high-frequency-specific (8-14 kHz) ABRs with reliable intrasubject latencies over time. This instrumentation is limited, however, because it cannot be transported to the patient confined to a hospital room. A portable device has now been constructed to deliver high-frequency (8-14 kHz) tone-burst stimuli comparable to the lab system. This digital/analog high-frequency tone-burst stimulus generator weighs less than 5 pounds. It can be utilized with any ABR signal averager capable of generating a positive (condensing) click at approximately 4.8 volts. Case studies are presented to demonstrate the frequency-specific responses obtained with these high-frequency tone-burst stimuli.

Entities:  

Mesh:

Year:  1992        PMID: 1581591

Source DB:  PubMed          Journal:  J Am Acad Audiol        ISSN: 1050-0545            Impact factor:   1.664


  3 in total

1.  Distortion-product otoacoustic emission test performance for ototoxicity monitoring.

Authors:  Kelly M Reavis; Garnett McMillan; Donald Austin; Frederick Gallun; Stephen A Fausti; Jane S Gordon; Wendy J Helt; Dawn Konrad-Martin
Journal:  Ear Hear       Date:  2011-02       Impact factor: 3.570

2.  Hydrochlorothiazide and risk of hearing disorder: a case series.

Authors:  Natnael Belai; Selamawit Gebrehiwet; Yodit Fitsum; Mulugeta Russom
Journal:  J Med Case Rep       Date:  2018-05-20

3.  Reversible ototoxicity: a rare adverse reaction of liposomal amphotericin-B used for the treatment of antimony-resistant visceral leishmaniasis in an elderly male.

Authors:  Pc Das; Ramesh Kandel; Kapil Sikka; Ab Dey
Journal:  Clin Med Insights Case Rep       Date:  2014-07-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.